Skip to content

Clinical trials

Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Country / region: United States Clear all

487 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
200310
20046
20055
200610
200712
200817
200920
20109
201116
201214
201312
201417
201514
201610
201725
201819
201921
202025
202128
202234
202335
202415
202542
202654

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed234
Recruiting100
Terminated38
Not yet recruiting26
Active, not recruiting25
Unknown status24
Withdrawn22
Enrolling by invitation16
No longer available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital10
Johns Hopkins University9
Duke University8
Mayo Clinic7
University of California, San Francisco7
NYU Langone Health6
National Cancer Institute (NCI)6
National Institute of Allergy and Infectious Diseases (NIAID)6
Institute for Neurodegenerative Disorders5
Stanford University5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease487
Prostatic Neoplasms29
Lung Neoplasms24
Neoplasms19
Breast Neoplasms15
Alzheimer Disease13
Asthma13
Cognitive Dysfunction12
Colorectal Neoplasms11
Dementia10

Trials

Showing 26 to 50 of 487. Each trial links to its page on Pharma Observatory.

387 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.